| Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases S Nami, A Aghebati-Maleki, H Morovati, L Aghebati-Maleki Biomedicine & Pharmacotherapy 110, 857-868, 2019 | 152 | 2019 |
| Fungal vaccines, mechanism of actions and immunology: A comprehensive review S Nami, R Mohammadi, M Vakili, K Khezripour, H Mirzaei, H Morovati Biomedicine & Pharmacotherapy 109, 333-344, 2019 | 133 | 2019 |
| Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis E Ahmadpour, H Safarpour, L Xiao, M Zarean, K Hatam-Nahavandi, ... Parasite 27, 2020 | 49 | 2020 |
| Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis KK Rad, M Falahati, M Roudbary, S Farahyar, S Nami Current medical mycology 2 (4), 24, 2016 | 48 | 2016 |
| Global prevalence and subgroup analyses of coronavirus disease (COVID‐19) associated Candida auris infections (CACa): A systematic review and meta‐analysis N Vaseghi, J Sharifisooraki, H Khodadadi, S Nami, F Safari, ... Mycoses 65 (7), 683-703, 2022 | 45 | 2022 |
| The Urtica dioica extract enhances sensitivity of paclitaxel drug to MDA-MB-468 breast cancer cells A Mohammadi, B Mansoori, M Aghapour, S Shirjang, S Nami, ... Biomedicine & Pharmacotherapy 83, 835-842, 2016 | 41 | 2016 |
| Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis E Ahmadpour, ZG Azar, A Spotin, R Norouzi, H Hamishehkar, S Nami, ... Parasitology Research 469 (2019), 2019 | 37 | 2019 |
| Current applications and prospects of nanoparticles for antifungal drug delivery S Nami, A Aghebati-Maleki, L Aghebati-Maleki EXCLI Journal 20, 562-584, 2021 | 33 | 2021 |
| Molecular Phylodiagnosis of Enterocytozoon bieneusi and Encephalitozoon intestinalis in Children with Cancer: Microsporidia in Malignancies as an Emerging Opportunistic Infection SM Roghayeh Ghoyounchi, Mahmoud Mahami-Oskouei, Azim Rezamand, Adel Spotin ... Acta parasitologica 64 (1), 103-111, 2019 | 26 | 2019 |
| TLR-2, IL-10 and IL-17-mediated immunity in experimental chemotherapy murine model of systemic candidiasis; cyclophosphamides' impact and roles P Dehghan, S Tolouie, B Baradaran, S Nami, H Morovati Microbial Pathogenesis 119, 183-192, 2018 | 21 | 2018 |
| Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects AS Nayer Mehdizad Bakhtiar, Abolfazl Akbarzadeh, Adriano Casulli, Mahmoud ... Parasitology Research 118 (9), 2455-2466, 2019 | 20 | 2019 |
| Implications of exosomes as diagnostic and therapeutic strategies in cancer A Aghebati‐Maleki, S Nami, A Baghbanzadeh, BH Karzar, S Noorolyai, ... Journal of Cellular Physiology 234 (12), 21694-21706, 2019 | 19 | 2019 |
| The utilization of RNA silencing technology to mitigate the voriconazole resistance of aspergillus flavus; lipofectamine-based delivery S Nami, B Baradaran, B Mansoori, P Kordbacheh, S Rezaie, M Falahati, ... Advanced Pharmaceutical Bulletin 7 (1), 53, 2017 | 18 | 2017 |
| Interactions between immune response to fungal infection and microRNAs: the pioneer tuners K Pakshir, H Badali, S Nami, H Mirzaei, V Ebrahimzadeh, H Morovati Mycoses 63 (1), 4-20, 2020 | 16 | 2020 |
| Is mannose‐binding lectin serum concentration a reliable predictor for recurrent vulvovaginal candidiasis? M Ghazanfari, M Falahati, A Fattahi, F Bazrafshan, S Nami, ... Mycoses 62 (2), 106-111, 2019 | 12 | 2019 |
| Antifungal effects of voriconazole-loaded nano-liposome on fluconazole-resistant clinical isolates of Candida albicans, biological activity and ERG11, CDR1, and CDR2 gene … P Hassanpour, H Hamishehkar, B Bahari Baroughi, B Baradaran, ... ASSAY and Drug Development Technologies 19 (7), 453-462, 2021 | 11 | 2021 |
| Prevalence of Candida albicans and Trichomonas vaginalis Infections in women M Falahati, L Akhlaghi, M Abianeh, M Assadi, S Nami, R Fateh Life Sci J 10 (5), 479-483, 2013 | 11 | 2013 |
| An appraisal of antifungal impacts of nano-liposome containing voriconazole on voriconazole-resistant Aspergillus flavus isolates as a groundbreaking drug delivery system P Hassanpour, H Hamishehkar, B Baradaran, M Mohammadi, N Shomali, ... Nanomed Res J 5 (1), 2020 | 10 | 2020 |
| Comparision of antifungal effect of fluconazole alone and in combination with nanosilver particles against candida species isolated from chronic candidal vulvovaginitis N Shima, F Haydari, M Ashrafi, A Farzaneh, G Zeinab, N Sanam, ... | 10 | 2012 |
| Increased urine interleukin-17 and interleukin-22 levels in patients with candidal urinary tract infection K Ahmadikia, P Kordbacheh, P Shadpour, S Nami, A Sarrafnejad, ... Iranian journal of kidney diseases 12 (1), 33, 2018 | 7 | 2018 |
Adel SpotinAssociate professor at Tabriz University of Medical Sciences, IranVerified email at tbzmed.ac.ir
